10x Genomics

10x Genomics, Inc. is a prominent American life science technology company dedicated to accelerating the mastery of biology to advance human health. Founded in 2012 and headquartered in Pleasanton, California, the company designs, manufactures, and sells innovative and integrated solutions for in-depth biological analysis. These solutions, which include instruments, consumables, and software, empower researchers to explore biological systems at a resolution and scale that matches the complexity of life itself. The company's product portfolio is built around several key platforms, including the Chromium Single Cell platform, the Visium Spatial platform, and the Xenium platform for in situ analysis. These technologies enable scientists to perform high-throughput single-cell analysis, understand the spatial arrangement of gene activity within tissues, and profile the transcriptome with subcellular resolution.

The company's tools have become indispensable in numerous fields of biological research, including oncology, immunology, neuroscience, and developmental biology. By providing a detailed view of cellular heterogeneity, cell-to-cell interactions, and spatial context, 10x Genomics' technologies have been instrumental in over 8,200 scientific publications and have contributed to significant breakthroughs. Researchers at top-tier academic institutions, translational research centers, and biopharmaceutical companies worldwide utilize these platforms to unravel the complexities of disease, identify new therapeutic targets, and develop next-generation diagnostics. With a strong commitment to innovation, evidenced by over 1,750 patents filed or issued, 10x Genomics continues to push the boundaries of scientific discovery, fueling progress toward a deeper understanding and eventual mastery of human health.